SIMA

FR:SIMASTOCK

Groupe Bils-Deroo

  • Privately Held

Company Overview

Metric
Company NameGroupe Bils-DerooACTEOS S.A.Claris HealthcareDecathlon
SymbolEOS
MSH IDFR:SIMASTOCKCOM:ACTEOSCOM:CLARISREFLEXCOM:DECATHLON
MarketPRIVATESTOCKSPRIVATEPRIVATE
SectorTransportationTechnologyHealthcare & Health ServicesConsumer Goods
IndustryLogistics and TransportationSoftware - ApplicationHealthcare TechnologySporting Goods Retail
CountryFRFRUSNL
Stage
Employee Count80
Websitesimastock.fracteos.comclarisreflex.comdecathlon.com
LinkedIn
Founders

Market Metrics

Metric
Market Cap4.76M
Enterprise Value
Monthly Web Traffic7.99M
Web Traffic Growth0.03
Valuation
Raised Capital

Financial Performance

Metric
Revenue15.36M
Revenue (LTM)
Revenue (NTM)
Gross Profit8.98M
EBITDA15.36M
Operating Income-53.87K
Net Income-141.53K
EPS-0.04
Diluted EPS-0.04
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.28
Operating Profit Margin0.05
EBITDA Margin1
Net Profit Margin-0.01
Return on Equity0.34
Return on Assets
Return on Capital Employed0.24

Valuation Multiples

Metric
P/E Ratio-30.67
P/B Ratio-14.24
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio0.32
EV Multiple1.14

Operational Metrics

Metric
Days Sales Outstanding128.36
Days Payables Outstanding50.55
Days Inventory Outstanding8.67
Operating Cycle122.62
Cash Conversion Cycle62.84
Asset Turnover0.97

Cash Flow Metrics

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales-0.04
Free Cash Flow Yield0.22

Balance Sheet Metrics

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization1.23
Debt to Assets0.36
Current Ratio0.93
Quick Ratio0.84

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue0.16